Jørgen Vestbo

93.1k total citations · 24 hit papers
556 papers, 49.7k citations indexed

About

Jørgen Vestbo is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Jørgen Vestbo has authored 556 papers receiving a total of 49.7k indexed citations (citations by other indexed papers that have themselves been cited), including 447 papers in Pulmonary and Respiratory Medicine, 240 papers in Physiology and 51 papers in Epidemiology. Recurrent topics in Jørgen Vestbo's work include Chronic Obstructive Pulmonary Disease (COPD) Research (405 papers), Respiratory Support and Mechanisms (196 papers) and Asthma and respiratory diseases (193 papers). Jørgen Vestbo is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (405 papers), Respiratory Support and Mechanisms (196 papers) and Asthma and respiratory diseases (193 papers). Jørgen Vestbo collaborates with scholars based in United Kingdom, Denmark and United States. Jørgen Vestbo's co-authors include Peter Lange, Paul Jones, Àlvar Agustí, Bartolomé R. Celli, Eva Prescott, Peter M.A. Calverley, Fernando J. Martínez, Claus Vogelmeier, Julie Yates and Leonardo M. Fabbri and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Jørgen Vestbo

534 papers receiving 48.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

2012 9.4k citations Jørgen Vestbo, Àlvar Agustí et al. American Journal of Respiratory and Critical Care Medicine profile →
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease

2007 2.3k citations Christine Jenkins, Paul Jones et al. profile →
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

2010 2.1k citations Jørgen Vestbo, Hana Müllerová et al. profile →
A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma

1998 935 citations Peter Lange, Jørgen Vestbo et al. profile →
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

2003 894 citations Jørgen Vestbo, Paul Jones et al. profile →
Characterisation of COPD heterogeneity in the ECLIPSE cohort

2010 822 citations Àlvar Agustí, Ruth Tal‐Singer et al. profile →
Prognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease

1999 752 citations Peter Lange, Jørgen Vestbo et al. American Journal of Respiratory and Critical Care Medicine profile →
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease

2015 739 citations Peter Lange, Àlvar Agustí et al. profile →
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD

2010 726 citations Àlvar Agustí, Paul Jones et al. American Journal of Respiratory and Critical Care Medicine profile →
Changes in Forced Expiratory Volume in 1 Second over Time in COPD

2011 680 citations Jørgen Vestbo, Julie Yates et al. profile →
Treatable traits: toward precision medicine of chronic airway diseases

2016 653 citations Àlvar Agustí, Elisabeth H. Bel et al. European Respiratory Journal profile →
Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype

2012 620 citations Àlvar Agustí, Stephen I. Rennard et al. profile →
Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

1999 594 citations Jørgen Vestbo, Peter Lange et al. profile →
Association of Chronic Mucus Hypersecretion With FEV1 Decline and Chronic Obstructive Pulmonary Disease Morbidity. Copenhagen City Heart Study Group

1996 547 citations Jørgen Vestbo et al. American Journal of Respiratory and Critical Care Medicine profile →
Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

2016 547 citations Jørgen Vestbo, Claus Vogelmeier et al. profile →
Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH Study

2008 541 citations Christine Jenkins, Paul Jones et al. American Journal of Respiratory and Critical Care Medicine profile →
Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

2008 510 citations Jørgen Vestbo, Ruth Tal‐Singer et al. European Respiratory Journal profile →
Chronic obstructive pulmonary disease

2015 458 citations Jørgen Vestbo et al. profile →
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline

2017 452 citations Alberto Papi, Jørgen Vestbo et al. European Respiratory Journal profile →
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial

2018 398 citations Alberto Papi, Jørgen Vestbo et al. profile →
Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease

2012 313 citations Julie Yates, Ruth Tal‐Singer et al. American Journal of Respiratory and Critical Care Medicine profile →
Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial

2016 312 citations Jørgen Vestbo, Julie Yates et al. profile →
Prediction of the Clinical Course of Chronic Obstructive Pulmonary Disease, Using the New GOLD Classification: A Study of the General Population

2012 287 citations Peter Lange, Jacob Louis Marott et al. American Journal of Respiratory and Critical Care Medicine profile →
The need for clean air: The way air pollution and climate change affect allergic rhinitis and asthma

2020 277 citations Alexander G. Mathioudakis, Jørgen Vestbo et al. profile →

Peers

Countries citing papers authored by Jørgen Vestbo

Since Specialization

Citations

This map shows the geographic impact of Jørgen Vestbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jørgen Vestbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jørgen Vestbo more than expected).

Fields of papers citing papers by Jørgen Vestbo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jørgen Vestbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jørgen Vestbo. The network helps show where Jørgen Vestbo may publish in the future.

Co-authorship network of co-authors of Jørgen Vestbo

This figure shows the co-authorship network connecting the top 25 collaborators of Jørgen Vestbo. A scholar is included among the top collaborators of Jørgen Vestbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jørgen Vestbo. Jørgen Vestbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Low smoking exposure and development and prognosis of COPD over four decades: a population-based cohort study 2024 ·European Respiratory Journal ·Yunus Çolak, Anders Løkke, Jacob Louis Marott, Peter Lange, Jørgen Vestbo, Børge G. Nordestgaard, Shoaib Afzal	4
2	Susceptible Young Adults and Development of Chronic Obstructive Pulmonary Disease Later in Life 2024 ·American Journal of Respiratory and Critical Care Medicine ·Yunus Çolak, Peter Lange, Jørgen Vestbo, Børge G. Nordestgaard, Shoaib Afzal	8
3	Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY 2024 ·Therapeutic Advances in Respiratory Disease ·Alberto Papi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jørgen Vestbo, (unknown), Pierre‐Régis Burgel, David Price	3
4	Predicting exacerbations in COPD in the Danish general population 2024 ·Respiratory Medicine ·Jacob Louis Marott, Truls Sylvan Ingebrigtsen, Yunus Çolak, Jørgen Vestbo, Børge G. Nordestgaard, Peter Lange	2
5	Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients 2023 ·Biomedicines ·(unknown), Pradeesh Sivapalan, Josefin Eklöf, (unknown), (unknown), Christian B. Laursen, Jørgen Vestbo, Christine Jenkins, Rune Nielsen, Per Bakke, (unknown), Daniel Modin, Niklas Dyrby Johansen, (unknown), Tor Biering‐Sørensen, Jørn Carlsen, Jens‐Ulrik Stæhr Jensen	3
6	Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD 2023 ·ERJ Open Research ·(unknown), (unknown), David Baldwin, Richard Booton, Mike Darby, (unknown), Rhian Gabe, Neil Hancock, Sam M. Janes, Martyn Kennedy, (unknown), Richard D Neal, Suzanne Rogerson, Bethany Shinkins, (unknown), (unknown), Jørgen Vestbo, Philip Crosbie, Matthew Callister	8
7	Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe 2022 ·European Respiratory Review ·Constantine Vardavas, Alexander G. Mathioudakis, Katerina Nikitara, Κimon Stamatelopoulos, Georgios Georgiopoulos, Revati Phalkey, Jo Leonardi‐Bee, Esteve Fernández, Dolors Carnicer-Pont, Jørgen Vestbo, Jan C. Semenza, Charlotte Deogan, Jonathan E. Suk, Piotr Kramarz, Favelle Lamb, Pasi Penttinen	55
8	Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort 2021 ·European Respiratory Journal ·Helen K. Reddel, Jørgen Vestbo, Àlvar Agustí, Gary P. Anderson, Aruna T. Bansal, Richard Beasley, Elisabeth H. Bel, Christer Janson, Barry J. Make, Ian Pavord, David Price, Eleni Rapsomaniki, Niklas Karlsson, Donna K. Finch, Javier Nuevo, (unknown), Marianna Alacqua, Rod Hughes, Hana Müllerová, Maria Gerhardsson de Verdier, (unknown)	44
9	Management of chronic obstructive pulmonary disease 2021 ·British Journal of Hospital Medicine ·(unknown), (unknown), (unknown), Jørgen Vestbo	7
10	Corticosteroid Resistance in Smokers—A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial 2021 ·Journal of Clinical Medicine ·Pradeesh Sivapalan, András Bikov, Charlotte Suppli Ulrik, Thérèse Lapperre, Alexander G. Mathioudakis, (unknown), Kristoffer Grundtvig Skaarup, Tor Biering‐Sørensen, Jørgen Vestbo, Jens‐Ulrik Stæhr Jensen	2
11	Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality 2020 ·American Journal of Respiratory and Critical Care Medicine ·Jacob Louis Marott, Truls Sylvan Ingebrigtsen, Yunus Çolak, Jørgen Vestbo, Peter Lange	59
12	Automatic oxygen titration with O2matic® to patients admitted with COVID-19 and hypoxemic respiratory failure 2020 ·European Clinical Respiratory Journal ·Ejvind Frausing Hansen, (unknown), Jørgen Vestbo, Ove Andersen, (unknown)	9
13	Prevalence, Characteristics, and Prognosis of Early Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study 2019 ·American Journal of Respiratory and Critical Care Medicine ·Yunus Çolak, Shoaib Afzal, Børge G. Nordestgaard, Jørgen Vestbo, Peter Lange	65
14	Prognosis of COPD depends on severity of exacerbation history: A population-based analysis 2019 ·Respiratory Medicine ·Yunus Çolak, Shoaib Afzal, Jacob Louis Marott, Børge G. Nordestgaard, Jørgen Vestbo, Truls Sylvan Ingebrigtsen, Peter Lange	34
15	Psychometric Properties of the COPD-Specific Beliefs About Medicine Questionnaire in an Outpatient Population: A Rasch-Analysis 2016 ·Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ·(unknown), Jørgen Vestbo, Erik Lykke Mortensen	4
16	Overweight and Obesity May Lead to Under-diagnosis of Airflow Limitation: Findings from the Copenhagen City Heart Study 2014 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·Yunus Çolak, Jacob Louis Marott, Jørgen Vestbo, Peter Lange	38
17	The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort 2013 ·European Respiratory Journal ·Daisy J.A. Janssen, Àlvar Agustí, Hana Müllerová, Julie Yates, Ruth Tal‐Singer, Stephen I. Rennard, Jørgen Vestbo, (unknown)	1
18	FORWARD: A study of extrafine beclomethasone/formoterol compared with formoterol alone in patients with severe COPD and a history of exacerbations 2013 ·European Respiratory Journal ·Àlvar Agustí, Massimo Corradi, Géraldine Cohuet, Stefano Vezzoli, Dave Singh, Jørgen Vestbo, Pierluigi Paggiaro, Paul Jones, Stefano Petruzzelli, (unknown)	1
19	Onset of Effect of Aclidinium, a Novel, Long-Acting Muscarinic Antagonist, in Patients with COPD 2010 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·Jørgen Vestbo, Claus Vogelmeier, Jacques P.H.M. Creemers, (unknown), Anna Feliu, Esther García Gil	25
20	Developing COPD: a 25 year follow up study of the general population 2006 ·Thorax ·Anders Løkke, Peter Lange, Henrik Scharling, P. G. Fabricius, Jørgen Vestbo	432

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact